Compare EVAX & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | ABLV |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | Denmark | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 39.5M |
| IPO Year | 2021 | N/A |
| Metric | EVAX | ABLV |
|---|---|---|
| Price | $5.21 | $0.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 89.1K | 12.9K |
| Earning Date | 11-06-2025 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $7,650,000.00 | ★ $114,319,869.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.74 |
| Revenue Growth | ★ 132.17 | N/A |
| 52 Week Low | $1.20 | $0.59 |
| 52 Week High | $12.15 | $1.77 |
| Indicator | EVAX | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 39.55 |
| Support Level | $4.56 | $0.62 |
| Resistance Level | $5.48 | $0.75 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 41.18 | 21.96 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.